Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2012

01.10.2012 | Maternal-Fetal Medicine

Pregnancy outcomes in women with Ebstein’s anomaly

verfasst von: WeiXiu Zhao, Hua Liu, Ran Feng, JianHua Lin

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate whether women with Ebstein’s anomaly can tolerate pregnancy and whether the perinatal outcomes are influenced by the severity of Ebstein’s anomaly.

Methods

Data of four women with Ebstein’s anomaly delivered in our unit were collected and analyzed retrospectively.

Results

(1) Two women with Ebstein’s anomaly had uneventful pregnancies, cesarean section and puerperium. (2) The patient with the most serious Ebstein’s anomaly (with central cyanosis and clubbing) had an episode of paroxysmal ventricular tachycardia and spontaneous cardioversion to sinus rhythm on day 4 postpartum. She developed intracerebral hemorrhage on day 25 postpartum. (3) One of them suffered from atrial flutter on 38 + 3 weeks of gestation which was restored to sinus rhythm after being treated with verapamil and remained stable afterward. (4) All neonatal birth weights were more than 2,500 g, and all neonatal Apgar scores were 10 at 1 min. (5) The gestational age at delivery of our cases was from week 36 + 4 to week 38 + 4. The mean duration of follow-up was 56 days postpartum.

Conclusions

(1) The clinical features of pregnant women with Ebstein’s anomaly vary. They might have good perinatal outcomes when given appropriate treatment. (2) Those with cyanosis should be given more attention, as they can have more complications during pregnancy, delivery and puerperium. (3) All women with Ebstein’s anomaly should be offered fetal echocardiography during pregnancy. (4) Vaginal delivery is advised for most cases with Ebstein’s anomaly.
Literatur
1.
Zurück zum Zitat Donnelly JE, Brown JM, Radford DJ (1991) Pregnancy outcome and Ebstein’s anomaly. Br Heart J 66:368–371PubMedCrossRef Donnelly JE, Brown JM, Radford DJ (1991) Pregnancy outcome and Ebstein’s anomaly. Br Heart J 66:368–371PubMedCrossRef
2.
Zurück zum Zitat Paranon S, Acar P (2008) Ebstein’s anomaly of the tricuspid valve: from fetus to adult. Heart 94:237–243PubMedCrossRef Paranon S, Acar P (2008) Ebstein’s anomaly of the tricuspid valve: from fetus to adult. Heart 94:237–243PubMedCrossRef
3.
Zurück zum Zitat Littler WA (1970) Successful pregnancy in a patient with Ebstein’s anomaly. Br Heart J 32:711–713PubMedCrossRef Littler WA (1970) Successful pregnancy in a patient with Ebstein’s anomaly. Br Heart J 32:711–713PubMedCrossRef
4.
Zurück zum Zitat Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R, Mayet J, Francis DP (2007) Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 93(4):476–482PubMedCrossRef Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R, Mayet J, Francis DP (2007) Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 93(4):476–482PubMedCrossRef
5.
Zurück zum Zitat Giuliani ER, Fuster V, Brandenburg RO, Mair DD (1979) Ebstein’s anomaly: the clinical features and natural history of Ebstein’s anomaly of the tricuspid valve. Mayo Clin Proc 54:163–173PubMed Giuliani ER, Fuster V, Brandenburg RO, Mair DD (1979) Ebstein’s anomaly: the clinical features and natural history of Ebstein’s anomaly of the tricuspid valve. Mayo Clin Proc 54:163–173PubMed
7.
Zurück zum Zitat Choi YH, Park JH, Choe YH, Yoo SJ (1994) MR imaging of Ebstein’s anomaly of the tricuspid valve. Am J Roentgenol 163:539–543 Choi YH, Park JH, Choe YH, Yoo SJ (1994) MR imaging of Ebstein’s anomaly of the tricuspid valve. Am J Roentgenol 163:539–543
8.
Zurück zum Zitat Sommer RJ, Hijazi ZM, Rhodes JF (2008) Pathophysiology of congenital heart disease in the adult: part III: complex congenital heart disease. Circulation 117(10):1340–1350PubMedCrossRef Sommer RJ, Hijazi ZM, Rhodes JF (2008) Pathophysiology of congenital heart disease in the adult: part III: complex congenital heart disease. Circulation 117(10):1340–1350PubMedCrossRef
10.
Zurück zum Zitat Groves ER, Groves JB (1995) Epidural analgesia for labour in a patient with Ebstein’s anomaly. Can J Anaesth 42(1):77–79PubMedCrossRef Groves ER, Groves JB (1995) Epidural analgesia for labour in a patient with Ebstein’s anomaly. Can J Anaesth 42(1):77–79PubMedCrossRef
11.
Zurück zum Zitat Shina A, Seward JB, Edwards WD, Hagler DJ, Tajik AJ (1984) Two-dimensional echocardiographic spectrum of Ebstein’s anomaly: detailed anatomic assessment. J Am Col Cardiol 3:356–370CrossRef Shina A, Seward JB, Edwards WD, Hagler DJ, Tajik AJ (1984) Two-dimensional echocardiographic spectrum of Ebstein’s anomaly: detailed anatomic assessment. J Am Col Cardiol 3:356–370CrossRef
12.
Zurück zum Zitat Chopra S, Suri V, Aggarwal N, Rohilla M, Vijayvergiya R, Keepanasseril A (2010) Ebstein’s anomaly in pregnancy: maternal and neonatal outcomes. J Obstet Gynaecol Res 36(2):278–283PubMedCrossRef Chopra S, Suri V, Aggarwal N, Rohilla M, Vijayvergiya R, Keepanasseril A (2010) Ebstein’s anomaly in pregnancy: maternal and neonatal outcomes. J Obstet Gynaecol Res 36(2):278–283PubMedCrossRef
13.
Zurück zum Zitat Macfarlane AJ, Moise S, Smith D (2007) Caesarean section using total intravenous anaesthesia in a patient with Ebstein’s anomaly complicated by supraventricular tachycardia. Int J Obstet Anesth 16:155–159PubMedCrossRef Macfarlane AJ, Moise S, Smith D (2007) Caesarean section using total intravenous anaesthesia in a patient with Ebstein’s anomaly complicated by supraventricular tachycardia. Int J Obstet Anesth 16:155–159PubMedCrossRef
14.
Zurück zum Zitat Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, Scarselli GF, Gensini GF, Abbate R (2005) Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 45:86–91PubMed Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, Scarselli GF, Gensini GF, Abbate R (2005) Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 45:86–91PubMed
15.
Zurück zum Zitat Connolly HM, Warnes CA (1994) Ebstein’s anomaly: outcome of pregnancy. J Am Coll Cardiol 23:1194–1198PubMedCrossRef Connolly HM, Warnes CA (1994) Ebstein’s anomaly: outcome of pregnancy. J Am Coll Cardiol 23:1194–1198PubMedCrossRef
16.
Zurück zum Zitat Huff RW (1989) Asthma in pregnancy. Med Clin North Am 73:653–660PubMed Huff RW (1989) Asthma in pregnancy. Med Clin North Am 73:653–660PubMed
17.
Zurück zum Zitat Abbas AE, Lester SJ, Connolly H (2005) Pregnancy and the cardiovascular system. Int J Cardiol 98(2):179–189PubMedCrossRef Abbas AE, Lester SJ, Connolly H (2005) Pregnancy and the cardiovascular system. Int J Cardiol 98(2):179–189PubMedCrossRef
18.
Zurück zum Zitat Draisci G, Valente A, Suppa E, Frassanito L, Pinto R, Meo F, De Sole P, Bossù E, Zanfini BA (2008) Remifentanil for cesarean section under general anesthesia: effects on maternal stress hormone secretion and neonatal well-being: a randomized trial. Int J Obstet Anesth 17(2):130–136PubMedCrossRef Draisci G, Valente A, Suppa E, Frassanito L, Pinto R, Meo F, De Sole P, Bossù E, Zanfini BA (2008) Remifentanil for cesarean section under general anesthesia: effects on maternal stress hormone secretion and neonatal well-being: a randomized trial. Int J Obstet Anesth 17(2):130–136PubMedCrossRef
19.
Zurück zum Zitat Maghsoudloo M, Eftekhar N, Noyan Ashraf MA, Khan ZH, Peiravy Sereshkeh H (2011) Does intravenous fentanyl affect Apgar scores and umbilical vessel blood gas parameters in cesarean section under general anesthesia? Acta Med Iran 49(8):517–522PubMed Maghsoudloo M, Eftekhar N, Noyan Ashraf MA, Khan ZH, Peiravy Sereshkeh H (2011) Does intravenous fentanyl affect Apgar scores and umbilical vessel blood gas parameters in cesarean section under general anesthesia? Acta Med Iran 49(8):517–522PubMed
20.
Zurück zum Zitat European Society of Gynecology; Association for European Paediatric Cardiology; German Society for Gender Medicine; Authors/Task Force Members, Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L; ESC Committee for Practice Guidelines, Bax J, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Baumgartner H, Deaton C, Aguiar C, Al-Attar N, Garcia AA, Antoniou A, Coman I, Elkayam U, Gomez-Sanchez MA, Gotcheva N, Hilfiker-Kleiner D, Kiss RG, Kitsiou A, Konings KT, Lip GY, Manolis A, Mebaaza A, Mintale I, Morice MC, Mulder BJ, Pasquet A, Price S, Priori SG, Salvador MJ, Shotan A, Silversides CK, Skouby SO, Stein JI, Tornos P, Vejlstrup N, Walker F, Warnes C (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32(24):3147–3197 European Society of Gynecology; Association for European Paediatric Cardiology; German Society for Gender Medicine; Authors/Task Force Members, Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L; ESC Committee for Practice Guidelines, Bax J, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Baumgartner H, Deaton C, Aguiar C, Al-Attar N, Garcia AA, Antoniou A, Coman I, Elkayam U, Gomez-Sanchez MA, Gotcheva N, Hilfiker-Kleiner D, Kiss RG, Kitsiou A, Konings KT, Lip GY, Manolis A, Mebaaza A, Mintale I, Morice MC, Mulder BJ, Pasquet A, Price S, Priori SG, Salvador MJ, Shotan A, Silversides CK, Skouby SO, Stein JI, Tornos P, Vejlstrup N, Walker F, Warnes C (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32(24):3147–3197
21.
Zurück zum Zitat Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology (2003) Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 24(8):761–781 Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology (2003) Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 24(8):761–781
22.
Zurück zum Zitat Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–1900PubMedCrossRef Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–1900PubMedCrossRef
Metadaten
Titel
Pregnancy outcomes in women with Ebstein’s anomaly
verfasst von
WeiXiu Zhao
Hua Liu
Ran Feng
JianHua Lin
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-012-2386-3

Weitere Artikel der Ausgabe 4/2012

Archives of Gynecology and Obstetrics 4/2012 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.